PI3K (phosphoinositide 3-kinase) is a key regulator of cell growth, metabolism and survival. The frequent activation of the PI3K pathway in cancer has stimulated widespread interest in identifying potent and selective inhibitors of PI3K isoforms. The present paper highlights recent progress in identifying such molecules and the challenges that remain for efforts to pharmacologically target the PI3K family.
Conference Article| March 20 2007
Chemically targeting the PI3K family
- Views Icon Views
- Share Icon Share
Z.A. Knight, K.M. Shokat; Chemically targeting the PI3K family. Biochem Soc Trans 1 April 2007; 35 (2): 245–249. doi: https://doi.org/10.1042/BST0350245
Download citation file: